View Older Stories
-
RBC Capital Highlights Top Ideas and Focus Picks Across HPC, Beverages, and Packaged Food
-
Clorox (CLX) PT Lowered to $152 at Jefferies
-
Clorox (CLX) Tops Q1 EPS by 3c, Beats on Revenue
-
Clorox (CLX) call put ratio 1.3 calls to 1 put into quarter results
-
Goldman: 'Attractive options ahead of October FOMC'
-
Clorox (CLX) Added to JPM Negative Catalyst Watch
-
Clorox (CLX) PT Lowered at TD Cowen 'In Anticipation Of Guidance Cut'
-
Jefferies Reiterates Buy Rating on Clorox (CLX)
-
CloroxPro launches Screen+ sanitizing wipes for electronics
-
Clorox (CLX) Tops Q4 EPS by 66c, Beats on Revenue
-
Clorox (CLX) Raises Quarterly Dividend 1.6% to $1.24; 3.9% Yield
-
Cognizant (CTSH) sued by Clorox (CLX) over 2023 cyberattack
-
Citi Issues Slew of Catalyst Calls on US Beverage and Household and Personal Care Names
-
Clorox (CLX) PT Lowered to $135 at Citi, 'We have a cautious view on CLX into F4Q’25 earnings'
-
Clorox (CLX) PT Lowered to $145 at Jefferies
-
TD Cowen sees more cuts in CPG sector following Procter & Gamble news
-
U.S. Beverages and HPC: What changes with new China tariffs?
-
Clorox (CLX) Appoints Gina Boswell to its Board
-
Clorox (CLX) call put ratio 1 call to 1.5 puts with a focus on May 125 and 135 puts as share price down 2.3%
-
Clorox (CLX) PT Lowered to $167 at Jefferies
-
Raymond James Reiterates Market Perform Rating on Clorox (CLX)
-
Clorox (CLX) PT Lowered to $142 at Wells Fargo
-
Clorox (CLX) PT Lowered to $144 at JPMorgan
-
Clorox (CLX) PT Lowered to $140 at Evercore ISI
-
Clorox (CLX) PT Lowered to $134 at Goldman Sachs
-
After-hours movers: Palantir, Ford, Clorox and more
-
Clorox (CLX) Misses Q3 EPS by 12c, Misses on Revenue; Offers FY25 EPS Guidance
-
Clorox (CLX) May option implied volatility elevated into quarter results
-
Strategist Notes UBS 13g Filing in Clorox (CLX) is 'interesting', Sees Friday Filing as Bookkeeping Measure to 'set the record straight'
-
RBC Capital's Ideas and Focus Picks Ahead of March Q Earnings
-
Clorox (CLX) Declares $1.22 Quarterly Dividend; 3.1% Yield
-
Clorox (CLX) gains 2.7% on new virus concerns
-
Clorox (CLX) PT Lowered to $169 at DA Davidson
-
Goldman Sachs Reiterates Sell Rating on Clorox (CLX)
-
Clorox (CLX) PT Raised to $189 at Jefferies
-
Clorox (CLX) PT Lowered to $165 at Citi
-
After-hours movers: Palantir, NXP Semiconductors, Lumentum and more
-
Clorox (CLX) Tops Q2 EPS by 16c; offers guidance
-
DA Davidson on impact of tariffs on Health & Beauty/ Leisure stocks
-
Barclays Reiterates Underweight Rating on Clorox (CLX)
-
Clorox (CLX) February option implied volatility flat into quarter results
-
Clorox (CLX) February 160 straddle priced into quarter results
-
Clorox (CLX) Announces CFO Change
-
UBS Reiterates Neutral Rating on Clorox (CLX)
-
2025 Staples outlook and Q4 earnings preview
-
This consumer stock is a new 2025 Top Pick at Jefferies
-
Jefferies Reiterates Buy Rating on Clorox (CLX), '2025 Top Pick'
-
Clorox (CLX) Appoints Stephen Bratspies and Pierre Breber to its Board
-
Clorox (CLX) Declares $1.22 Quarterly Dividend; 2.9% Yield
-
TD Cowen Upgrades Clorox (CLX) to Hold

